Atlas FDA

Vivistim® System

FDA premarket approval P210007 · decided 2021-08-27

Approval details

PMA number
P210007
Trade name
Vivistim® System
Generic name
Stimulator, autonomic nerve, implanted for stroke rehabilitation
Applicant
Mobia Medical, Inc.
Date received
2021-03-02
Decision date
2021-08-27
Days to decision
178 days
Decision code
APPR
Product code
QPY
Advisory committee
Physical Medicine
Expedited review
No
Location
Austin, TX
Statement
Approval the MicroTransponder® Vivistim® Paired VNS System (Vivistim ® System) is intended to be used to stimulate the vagus nerve during rehabilitation therapy in order to reduce upper extremity motor deficits and improve motor function in chronic ischemic stroke patients with moderate to severe arm impairment.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.